You just read:

Sutro Initiates First Clinical Trial of CD74-Targeting ADC for Lymphoma & Multiple Myeloma Treatment; The First of a New Generation of Precisely Engineered ADCs

News provided by

Sutro Biopharma

Apr 26, 2018, 08:00 ET